PTPRN and colorectal carcinoma: Further experiments in PTPRN‐depleted cells showed that modulating TMEM59L expression no longer affected DNA damage or ROS levels (Figures S1 and S2), indicating that PTPRN is required for TMEM59L‐mediated regulation of 5‐FU resistance in CRC.